FENNEC PHARMACEUTICALS INC shareholders Q3 2023

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 57 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.6%.

FENNEC PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sonic GP LLC 2,407,357$18,079,25117.55%
Solas Capital Management, LLC 1,725,567$12,959,0089.07%
DG Capital Management, LLC 1,143,099$8,584,6734.70%
HARBERT FUND ADVISORS, INC. 466,869$3,506,1862.56%
AIGH Capital Management LLC 373,526$2,805,1801.33%
Southpoint Capital Advisors LP 4,077,214$30,619,8770.68%
APIS CAPITAL ADVISORS, LLC 70,000$525,7000.68%
Worth Venture Partners, LLC 92,636$695,6960.41%
Lion Point Capital, LP 110,000$826,1000.37%
683 Capital Management, LLC 300,000$2,253,0000.18%
Avoro Capital Advisors LLC 1,200,000$9,012,0000.14%
GENDELL JEFFREY L 285,992$2,147,8000.12%
EUDAIMONIA ADVISORS LLC 17,130$128,6470.09%
Hartford Financial Management Inc. 45,348$340,5640.09%
WEXFORD CAPITAL LP 26,414$198,3690.04%
HighMark Wealth Management LLC 3,000$22,5300.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 34,200$256,8420.01%
State of Wyoming 2,195$16,4840.00%
CIBC WORLD MARKET INC. 79,184$5950.00%
MetLife Investment Management, LLC 9,679$72,6890.00%
External links

This page lists FENNEC PHARMACEUTICALS INC's shareholders in Q3 2023. To view FENNEC PHARMACEUTICALS INC's shareholder history, click here.